Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Inflammation × Interleukin 1 Receptor Antagonist Protein × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 4 Mucositis 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, B-Cell 2 Febrile Neutropenia 2 Cytokine Release Syndrome 2 Burkitt Lymphoma 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Smoldering Multiple Myeloma 1 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Pancreatic Neoplasms 1 Pancreatic Adenocarcinoma 1 Neurotoxicity Syndromes 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Non-Hodgkin 1 Inflammation 1 Hematologic Neoplasms 1 Disease Progression 1 Cryopyrin-Associated Periodic Syndromes 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Arthritis, Rheumatoid 1

Interventions

Exercise 5 Omeprazole 3 Etanercept 3 salicylsalicylic acid 2 palbociclib 2 XENP 1595 2 Vitamin D 2 Tea 2 Tablets 2 Surgical Procedures, Operative 2 Sufentanil 2 Spironolactone 2 Resistance Training 2 Pioglitazone 2 Oxycodone 2 Nutrition Assessment 2 Metformin 2 Ketorolac 2 Ibuprofen 2 Fish Oils 2 Dexmedetomidine 2 Colchicine 2 Blood Specimen Collection 2 Aspirin 2 Ascorbic Acid 2 ziprasidone 1 soybean oil, phospholipid emulsion 1 semaglutide 1 montelukast 1 microcrystalline cellulose 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00537667 2009-11-26

The SPECTRA Study

Swedish Orphan Biovitrum

Phase 2 Terminated

Arthritis, Rheumatoid, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡